Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tambe

Showing results (601-610 of 750) with videos related to

Pageof 75
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized StudyVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
European Journal of Medicinal Chemistry|April 10, 2017
Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemiaAnil M Deshpande, Debnath Bhuniya, Siddhartha De, et al.
Plos One|February 20, 2014
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's diseaseGergely Tóth, Shyra J Gardai, Wagner Zago, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Discovery of a potent and selective small molecule hGPR91 antagonistDebnath Bhuniya, Dhananjay Umrani, Bhavesh Dave, et al.
Injury|August 4, 2024
Management of type III acromioclavicular joint dislocation: A Delphi consensus survey by Shoulder & Elbow Society, India (SESI)Darshil Shah, Dipit Sahu, Raju Easwaran, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Scientific Reports|November 20, 2019
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Thomas Neumann, Amandine Berthet, et al.
Nature Materials|August 4, 2015
Unjamming and cell shape in the asthmatic airway epitheliumJin-Ah Park, Jae Hun Kim, Dapeng Bi, et al.
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Neurophotonics|April 1, 2026
CoMind R1: a time-resolved interferometric optical neuromonitoring system for pulsatile cerebral blood flow measurement at late times-of-flightVeronika Parfentyeva, Anurag Behera, Stella Avtzi, et al.
Pageof 75

Showing results (601-610 of 750) with videos related to

Sort By:
Pageof 75
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized StudyVijay Maruti Patil, Vanita Noronha, Nandini Menon, et al.
European Journal of Medicinal Chemistry|April 10, 2017
Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemiaAnil M Deshpande, Debnath Bhuniya, Siddhartha De, et al.
Plos One|February 20, 2014
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's diseaseGergely Tóth, Shyra J Gardai, Wagner Zago, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Discovery of a potent and selective small molecule hGPR91 antagonistDebnath Bhuniya, Dhananjay Umrani, Bhavesh Dave, et al.
Injury|August 4, 2024
Management of type III acromioclavicular joint dislocation: A Delphi consensus survey by Shoulder & Elbow Society, India (SESI)Darshil Shah, Dipit Sahu, Raju Easwaran, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Scientific Reports|November 20, 2019
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Thomas Neumann, Amandine Berthet, et al.
Nature Materials|August 4, 2015
Unjamming and cell shape in the asthmatic airway epitheliumJin-Ah Park, Jae Hun Kim, Dapeng Bi, et al.
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Neurophotonics|April 1, 2026
CoMind R1: a time-resolved interferometric optical neuromonitoring system for pulsatile cerebral blood flow measurement at late times-of-flightVeronika Parfentyeva, Anurag Behera, Stella Avtzi, et al.
Pageof 75